Quarterly and annual results disclosed under 8-K Item 2.02.
ATOSSA THERAPEUTICS, INC. reported financial results for the fourth quarter and year ended December 31, 2025.
“On March 25, 2026, Atossa Therapeutics, Inc. (the “Company”) issued a press release announcing the fourth quarter and year ended December 31, 2025 financial results and providing a Company update.”
Energous Corp reported the year ended December 31, 2025 results: revenue $5.6 million, net income approximately $(9.6) million, or $(6.46) per basic and diluted share, EPS $(6.46) per basic and diluted share.
“EX-99.1 (EXHIBIT 99.1) --- EX-99.1 2 tm269500d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Energous Wireless Power Solutions Reports Fiscal Year 2025 Results - Reports Revenue of $5.6 Million – Posting fourth consecutive quarter of growth and highest recorded annual revenue in the Company’s history - - Lowest Quarterly Net Loss since 2013 – Evidencing further progress”
Celcuity Inc. reported financial results for the fourth quarter and fiscal year ended December 31, 2025.
“On March 25, 2026, Celcuity Inc. (the “Company”) issued a press release regarding the Company’s financial results for the fourth quarter and fiscal year ended December 31, 2025.”
CaliberCos Inc. reported the fourth quarter and full year ended December 31, 2025 results: revenue Platform revenue of $15.2 million, net income Platform net loss of $21.2 million, EPS $7.50 per diluted share. Guidance initiated.
“loss of $0.4 million, compared to Platform Adjusted EBITDA loss of $1.0 million Full Year 2025 Platform Financial Highlights (compared to Full Year 2024) • Platform revenue of $15.2 million, compared to $20.9 million ◦ Asset management revenue of $15.2 million reflecting the timing of project financings and development activity, drove the stated results • Platform”
Navan, Inc. reported Fiscal year 2027 (ending January 31, 2027) results: revenue Total revenue in the range of $866 - $874 million. Guidance initiated.
“For the fiscal year 2027 (ending January 31, 2027), Navan currently expects: ● Total revenue in the range of $866 - $874 million, representing year-over-year growth of 24% at the midpoint”
Navan, Inc. reported First quarter of fiscal year 2027 (ending April 30, 2026) results: revenue Total revenue in the range of $204 - $206 million. Guidance initiated.
“For the first quarter of fiscal year 2027 (ending April 30, 2026), Navan currently expects: ● Total revenue in the range of $204 - $206 million, representing year-over-year growth of 30% at the midpoint”
Navan, Inc. reported Full fiscal year 2026 results: revenue Total Revenue was $702 million, an increase of 31% year-over-year, net income GAAP net loss was $398 million, compared to a net loss of $181 million in the full fiscal year 2025.
“Full Year 2026 ● Total Revenue was $702 million, an increase of 31% year-over-year”
Navan, Inc. reported Fourth quarter fiscal year 2026 results: revenue Total Revenue was $178 million, an increase of 35% year-over-year, net income GAAP net loss was $73 million.
“Fourth Quarter 2026 ● Total Revenue was $178 million, an increase of 35% year-over-year”
Navan, Inc. reported for the fiscal quarter and year ended January 31, 2026 results: revenue Total Revenue was $178 million, an increase of 35% year-over-year, net income GAAP net loss was $73 million, compared to a net loss of $47 million in the fourth quarter of fiscal year 2025.
“on Form 8-K and is incorporated herein by reference. --- EX-99.1 (EX-99.1) --- Navan Announces Fourth Quarter and Full Fiscal Year 2026 Results Fourth Quarter Revenue Grew 35% Year-Over-Year to $178 million Achieved First Full Year of Positive Cash Flows from Operating Activities and Free Cash Flow, Reaching Milestone One Year Ahead of Target PALO”
MODIV INDUSTRIAL, INC. reported fourth quarter and year ended December 31, 2025 results: net income Fourth quarter 2025 net income attributable to common stockholders was $0.4 million. Full year 2025 net loss attributabl, EPS Full year 2025 ... $(0.31) per diluted share.
“Modiv Industrial Announces Fourth Quarter and Full Year 2025 Results Denver, CO, March 25, 2026 – Modiv Industrial, Inc.”
Ondas Inc. reported financial results for the fourth quarter and full year ended December 31, 2025.
“On March 25, 2026, Ondas Inc. (the “Company”) released a slide presentation which includes supplemental information relating to the Company’s financial and operating results for the fourth quarter and full year ended December 31, 2025.”
BeyondSpring Inc. reported financial results for the full year ended December 31, 2025.
“On March 25, 2026, BeyondSpring Inc. (the “Company”) issued a press release announcing its financial results for the full year ended December 31, 2025.”
EXICURE, INC. reported the year ended December 31, 2025 results: net income $4.9 million.
“The Company had a net loss of $4.9 million for the year ended December 31, 2025, compared to a net loss of $9.7 million for the year ended December 31, 2024.”
Serina Therapeutics, Inc. reported the year ended December 31, 2025 results: net income $19.4 million, EPS $(1.91) per basic and diluted share.
“The net loss attributable to Serina common stockholders for the year ended December 31, 2025 was $19.4 million, or $(1.91) per basic and diluted share”
Equillium, Inc. reported financial results for fourth quarter and fiscal year ended December 31, 2025.
“On March 25, 2026, Equillium, Inc. (the “Company”) announced its financial results for the fourth quarter and full year ended December 31, 2025 in the press release attached hereto as Exhibit 99.1 and incorporated herein by reference.”
Chewy, Inc. reported Fiscal fourth quarter ended February 1, 2026 results: revenue $3.26 billion, net income $39.2 million, EPS Basic $0.09, Diluted $0.09.
“Net sales of $3.26 billion improved 0.5 percent year over year or 8.1 percent on a normalized 13-week basis • Gross margin of 29.4 percent expanded 90 basis points year over year • Net income of $39.2 million, including share-based compensation expense and related taxes of $77.6 million • Net margin of 1.2 percent expanded 50 basis points year over year • Basic earnings per share of $0.09, an increase of $0.03 year over year • Diluted earnings per share of $0.09, an increase of $0.04 year over year”
Chewy, Inc. reported Fiscal year ended February 1, 2026 results: revenue $12.60 billion, net income $222.8 million, EPS Basic $0.54, Diluted $0.52.
“Net sales of $12.60 billion improved 6.2 percent year over year or 8.3 percent on a normalized 52-week basis • Gross margin of 29.8 percent expanded 60 basis points year over year • Net income of $222.8 million, including share-based compensation expense and related taxes of $311.2 million • Net margin of 1.8 percent contracted 150 basis points year over year (2) • Basic earnings per share of $0.54, a decrease of $0.39 year over year (2) • Diluted earnings per share of $0.52, a decrease of $0.39 year over year (2)”
Nkarta, Inc. reported the fourth quarter and year ended December 31, 2025 results: net income Net loss was $104.1 million, or $1.41 per basic and diluted share, for the full year 2025. Net loss was $27.4 million, o, EPS $1.41 per basic and diluted share (full year); $0.37 per basic and diluted share (fourth quarter).
“On March 25, 2026, Nkarta, Inc. (the “Company”) issued a press release announcing its financial results for the fourth quarter and year ended December 31, 2025.”
Valion Bio, Inc. reported year ended December 31, 2025 results: net income expected to be in the range of $8.8 million to $9.1 million.
“Net loss for the year ended December 31, 2025 is expected to be in the range of $8.8 million to $9.1 million, compared with $5.7 million for the year ended December 31, 2024.”
Planet 13 Holdings Inc. reported the full year ended December 31, 2025 results: revenue $103.4 million, net income Net loss of $63.9 million.
“Revenues were $103.4 million as compared to $116.4 million”
Planet 13 Holdings Inc. reported the three-month and twelve-month periods ended December 31, 2025 results: revenue $25.2 million, net income Net loss of $4.6 million.
“Planet 13 Announces Q4 2025 Financial Results ● Q4 2025 Revenue of $25.2 million ● Q4 2025 Net loss of $4.6 million”
CATO CORP reported full-year fiscal 2025 results: revenue $646.8 million, net income ($5.9) million, EPS ($0.31) per diluted share.
“million for the fourth quarter ended February 1, 2025. Same-store sales for the fourth quarter were flat compared to 2024. For the year, the Company's sales increased 0.7% to $646.8 million from 2024 sales of $642.1 million. Year-to-date same-store sales increased 4% compared to 2024. "Compared to 2024, our fiscal 2025 sales trend was encouraging although 2024 was”
CATO CORP reported fourth quarter ended January 31, 2026 results: revenue $150.0 million, net income ($10.7) million, EPS ($0.55) per diluted share.
“million or ($0.31) per diluted share compared to a net loss of ($18.1) million or ($0.97) per diluted share for 2024. Sales for the fourth quarter ended January 31, 2026 were $150.0 million, a decrease of 3.4% from sales of $155.3 million for the fourth quarter ended February 1, 2025. Same-store sales for the fourth quarter were flat compared to 2024. For the year,”
SeaStar Medical Holding Corp reported three months and year ended December 31, 2025 results: revenue approximately $2 million in net product revenue in 2026.
“On March 25, 2026, SeaStar Medical Holding Corp. (the "Company") issued a press release announcing its financial condition and results of operations for the three and twelve months ended December 31, 2025.”
Spectral AI, Inc. reported Year ending December 31, 2026 results: revenue $18.5 million. Guidance initiated.
“The Company is forecasting revenue of approximately $18.5 million for the year ending December 31, 2026, primarily reflecting the continued development of the Company’s DeepView System through the BARDA PBS Contract. This guidance does not include any material contributions from the sale of the DeepView System for the burn indication.”
Spectral AI, Inc. reported Fourth Quarter and Full Year ended December 31, 2025 results: revenue Full Year Research & Development Revenue of $19.7 Million; Q4 2025 Revenue of $3.8 Million, net income Net income for Q4 2025 was $0.6 million; Net loss for FY 2025 was $(7.6) million, EPS Q4 2025: $0.02 per diluted share; FY 2025: $(0.29) per diluted share.
“Research & Development Revenue Research & Development revenue for Q4 2025 was $3.8 million compared to $7.6 million, reflecting the anticipated reduction in research direct labor, clinical trial and other reimbursed study costs relative to 2024 as the Company moved closer to completion of the base phase of its contract with BARDA (the “BARDA PBS Contract”). Research & Development Revenue for FY 2025 decreased to $19.7 million from $29.6 million, reflecting the anticipated overall reduction in the Company’s reimbursed costs associated with the BARDA PBS Contract during 2025 following the Company’s submission of its De Novo application to the FDA. Gross Margin Gross margin for Q4 2025 was 39.8% compared to 44.0% due primarily to a lower percentage of reimbursed direct labor as a component of overall revenue from the BARDA PBS Contract. Gross margin for FY 2025 was 45.4% compared to 44.9%, reflecting a consistent mix of direct labor as a percentage of the total work performed on the BARDA”
Local Bounti Corporation/DE reported the twelve months ended December 31, 2025 results: revenue $48.4 million, net income $94.4 million.
“Sales increased 27% to $48.4 million in 2025, as compared to $38.1 million in 2024.”
Local Bounti Corporation/DE reported the three months ended December 31, 2025 results: revenue $12.5 million, net income $8.7 million.
“Sales increased 24% to $12.5 million in the fourth quarter of 2025, as compared to $10.1 million in the prior year period.”
Maze Therapeutics, Inc. reported financial results for the fourth quarter and year ended December 31, 2025.
“On March 25, 2026, Maze Therapeutics Inc. (the “Company”) issued a press release reporting its financial results for the fourth quarter and year ended December 31, 2025.”
QT IMAGING HOLDINGS, INC. reported the three and twelve months ended December 31, 2025 results: revenue $18.9 million. Guidance reaffirmed.
“QT Imaging Reports 2025 Fourth Quarter and Full Year Financial Results 2025 Revenue of $18.9 Million Exceeded Outlook with a Record 40 Scanners Shipped Affirms 2026 Revenue Guidance of $39 Million”
Lafayette Square USA, Inc. reported financial results for the fiscal year and fourth quarter ended December 31, 2025.
“On March 25, 2026, Lafayette Square USA, Inc. (the "Company") provided an investor presentation to its shareholders summarizing certain financial and performance information for the fiscal year and fourth quarter ended December 31, 2025. A copy of the investor presentation is attached hereto as Exhibit 99.1”
GCT Semiconductor Holding, Inc. reported 2025 fiscal full year ended December 31, 2025 results: revenue Net revenues were $2.9 million.
“Net revenues were $2.9 million, a 68.6% decrease from $9.1 million.”
GCT Semiconductor Holding, Inc. reported 2025 fiscal fourth quarter ended December 31, 2025 results: revenue Net revenues were $0.8 million.
“Net revenues were $0.8 million, a 57.5% decrease from $1.8 million.”
Journey Medical Corp reported the full year ended December 31, 2025 results: revenue $61.9 million, net income Net loss was $11.4 million, or $(0.47) per share basic and diluted, EPS $(0.47) per share basic and diluted.
“2 tm269707d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights Total revenues were $61.9 million in FY2025 compared to $56.1 million in FY2024 Emrosi TM generated net revenues of $14.7 million during the full-year period after its launch in early April 2025 Approximately”
Stran & Company, Inc. reported financial results for the fiscal year ended December 31, 2025.
“On March 25, 2026, Stran & Company, Inc. (the "Company") issued a press release announcing its financial results for the fiscal year ended December 31, 2025 and providing a business update.”
Cyngn Inc. reported FY 2025 results: net income 23.5 million, EPS 5.17.
“Revenue in 2025 was $219 thousand compared to $368 thousand in 2024.”
Cyngn Inc. reported Q4 2025 results: net income 5.7 million, EPS 0.78.
“Fourth quarter of 2025 revenue was $68.1 thousand compared to $306.4 thousand in the fourth quarter of 2024.”
Toppoint Holdings Inc. reported the year ended December 31, 2025 results: revenue $16,548,734, net income $(7,344,586).
“that we believe position us to support customers more effectively.” — Hok C. Chan, Chief Executive Officer 2025 Business Highlights ● Revenue increased 3.2% year over year to $16.5 million, reflecting strong growth in import and scrap metal transportation. ● Import revenue increased 36.0% to $4.8 million, while import loads increased 54.7% to 6,275. ● Scrap metal”
Health In Tech, Inc. reported the fourth quarter and full year ended December 31, 2025 results: revenue Full year 2025 revenues were $33.3 million, net income Full year 2025 net income was $1.3 million. Guidance initiated.
“Health In Tech Announces Fourth Quarter and Full Year 2025 Financial Results ● Full year 2025 Revenues of $33.3 million, up 71% YoY ● Full year 2025 Adjusted EBITDA of $4.1 million, up 81% YoY”
Picard Medical, Inc. reported the year ended December 31, 2025 results: revenue $4.94 million, net income $(27.0) million.
“be available shortly after the call on the Company’s website, picardmedical.com, and continue to be available for 60 days. Financial Results Revenue Total revenue for 2025 was $4.94 million, compared to $4.39 million in 2024, representing an increase of 12.5 percent. Product revenue was $4.75 million, while rental revenue was $0.19 million. Product revenue was”
Karman Holdings Inc. reported full fiscal year 2026 results: revenue $715 million to $730 million. Guidance raised.
“For the full fiscal year 2026, the Company increases its expectations for total revenue to between $715 million and $730 million, and for non-GAAP Adjusted EBITDA to between $207 million and $218 million, excluding any future acquisitions.”
Karman Holdings Inc. reported fourth quarter and fiscal year ended December 31, 2025 results: revenue $134.5 million for the quarter; $471.5 million for the year, net income $7.7 million for the quarter; $17.4 million for the year, EPS $0.06 per fully diluted share for the quarter; $0.13 per fully diluted share for the year. Guidance raised.
“Produced record quarterly revenue of $134.5 million, up 47.4% year over year • Generated record quarterly net income of $7.7 million, a 358% year over year increase, and earnings per fully diluted share of $0.06”
MILLERKNOLL, INC. reported third quarter of fiscal year 2026, which ended February 28, 2026 results: revenue $ 926.6, EPS $ 0.34.
“(Dollars in millions, except per share data) February 28, 2026 March 1, 2025 % Chg. February 28, 2026 March 1, 2025 % Chg. (13 weeks) (13 weeks) (39 weeks) (39 weeks) Net sales $ 926.6 $ 876.2 5.8 % $ 2,837.5 $ 2,708.1 4.8 % Gross margin % 38.1 % 37.9 % 38.5 % 38.6 % Operating expenses $ 308.0 $ 414.6 (25.7) % $ 946.3 $ 1,050.2 (9.9) % Adjusted operating”
ENERPAC TOOL GROUP CORP reported its second fiscal quarter ended February 28, 2026 results: revenue $155 million, net income $16.3 million, or $0.31 per diluted share, EPS $0.31 per diluted share.
“2 exh_991.htm PRESS RELEASE EdgarFiling EXHIBIT 99.1 Enerpac Tool Group Reports Second Quarter Fiscal 2026 Results Second Quarter of Fiscal 2026 Highlights * Net sales were $155 million, a 6% increase compared to the prior year, with a 2% increase in organic sales 1 . IT&S Product sales increased 6% organically, the highest growth in 10 quarters. Operating”
CINTAS CORP reported the third quarter of fiscal 2026 ended February 28, 2026 results: revenue $2.84 billion, net income $502.5 million, EPS $1.24. Guidance raised.
“25 2026 -- Cintas Corporation (Nasdaq: CTAS) today reported results for its fiscal 2026 third quarter ended February 28, 2026. Revenue for the third quarter of fiscal 2026 was $2.84 billion compared to $2.61 billion in last year’s third quarter, an increase of 8.9%. The organic revenue growth rate for the third quarter of fiscal 2026, which adjusts for the impacts”
PAYCHEX INC reported three and nine months ended February 28, 2026 results: revenue $1,808.9, EPS $1.56.
“For the three months ended For the nine months ended February 28, February 28, In millions, except per share amounts 2026 2025 Change (2) 2026 2025 Change (2) Total revenue $ 1,808.9 $ 1,509.0 20 % $ 4,906.5 $ 4,144.4 18 % Operating income $ 792.0 $ 691.8 14 % $ 1,905.8 $ 1,776.6 7 % Adjusted operating income (1) $ 863.2 $ 708.5 22 % $ 2,138.9 $ 1,793.3 19 %”
Armata Pharmaceuticals, Inc. reported the three months and full fiscal year ended December 31, 2025 results: net income $124.3 million, EPS $(3.42) per share.
“Armata Pharmaceuticals, Inc. announced its financial results for the three months and full fiscal year ended December 31, 2025, in the press release furnished hereto as Exhibit 99.1.”
Jefferies Financial Group Inc. reported quarter ended February 28, 2026 results: revenue $2,017,130, net income $155,700, EPS $0.70.
“155,700 $ 127,793 Diluted earnings per common share from continuing operations $ 0.70 $ 0.57 Return on adjusted tangible shareholders' equity 1 10.9 % 8.0 % Total net revenues $ 2,017,130 $ 1,593,019 Investment banking net revenues $ 1,017,293 $ 700,692 Capital markets net revenues $ 778,756 $ 698,284 Asset management net revenues $ 220,262 $ 191,715 Pre-tax”
WORTHINGTON ENTERPRISES, INC. reported the three-month period ended February 28, 2026 (the fiscal 2026 third quarter) results: revenue $378.7 million, net income $45.1 million, EPS $0.92.
“its fiscal 2026 third quarter ended February 28, 2026. Recent Developments and Third Quarter Highlights (all comparisons to the third quarter of fiscal 2025): • Net sales were $378.7 million, an increase of 24%. • Net earnings increased 15% to $45.1 million, while adjusted net earnings increased 7% to $48.5 million and adjusted EBITDA grew 15% to $84.6 million. •”
REED'S, INC. reported financial results for the three months and 12 months ended December 31, 2025.
“On March 24, 2026, Reed’s, Inc., a Delaware corporation (the “Company”), issued a press release announcing financial results for the quarter and year ended December 31, 2025.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.